NEW DELHI, May 18 (NNN-PTI) – The Indian government yesterday launched the first batch of its indigenous anti-COVID-19 drug, 2-deoxy-D-glucose (2-DG).
The drug, developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of India’s Defence Research and Development Organisation (DRDO), in collaboration with Dr. Reddy’s Laboratories (DRL), in the southern city, Hyderabad, is used to treat COVID-19 patients.
The first batch of the drug was handed over by the federal defence minister, Rajnath Singh, to the federal health minister, Harsh Vardhan, in the national capital New Delhi.
The 2-DG drug was recently given approval for emergency use, from the Drugs Controller General of India.
India has been hit by a devastating second wave of COVID-19 infections.
The health ministry, yesterday morning said, 281,386 new cases and 4,106 related deaths were registered in the past 24 hours across the country.– NNN-PTI
